SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition

Kim, Eunhee, Ilagan, Janine O., Liang, Yang, Daubner, Gerrit M., Lee, Stanley C.-W., Ramakrishnan, Aravind, Li, Yue, Chung, Young Rock +17 more·2015·Cancer Cell

DOI 10.1016/j.ccell.2015.04.006

Cited by (582)

Items 101–200 of 582

SRSF2 plays an unexpected role as reader of m5C on mRNA, linking epitranscriptomics to cancer
Haili Ma, Martin Bizet, Christelle Soares Da Costa, Frédéric Murisier, Eric James de Bony, Mengke Wang, Akihide Yoshimi, Kuan‐Ting Lin, Kristin M. Riching, Xing Wang et al. · 2023 · Molecular Cell
Uncovering the Role of RNA-Binding Proteins in Gene Expression in the Immune System
Manuel D. Díaz‐Muñoz, Martin Turner · 2018 · Frontiers in Immunology
Physiological Srsf2 P95H expression causes impaired hematopoietic stem cell functions and aberrant RNA splicing in mice
Ayana Kon, Satoshi Yamazaki, Yasuhito Nannya, Keisuke Kataoka, Yasunori Ota, Masahiro Marshall Nakagawa, Kenichi Yoshida, Yusuke Shiozawa, Maiko Morita, Tetsuichi Yoshizato et al. · 2017 · Blood
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy
Irene Gañán‐Gómez, Hui Yang, Feiyang Ma, Guillermo Montalban Bravo, Natthakan Thongon, Valentina Marchica, Guillaume Richard‐Carpentier, Kelly Sharon Chien, Ganiraju C. Manyam, Feng Wang et al. · 2022 · Nature Medicine
Molecular impact of mutations in RNA splicing factors in cancer
Qian Zhang, Yuxi Ai, Omar Ibrahim Abdel-Wahab · 2024 · Molecular Cell
Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3′ splice sites within RNA secondary structures
Anil K Kesarwani, Oscar Ramirez, A K Gupta, Xiaodong Yang, T Murthy, Alex C. Minella, Manoj M. Pillai · 2016 · Oncogene
Turning the tide in myelodysplastic/myeloproliferative neoplasms
Michael W. Deininger, Jeffrey W Tyner, Éric Solary · 2017 · Nature reviews. Cancer
Splicing heterogeneity: separating signal from noise
Yihan Wan, Daniel R. Larson · 2018 · Genome biology
Splicing Factors Have an Essential Role in Prostate Cancer Progression and Androgen Receptor Signaling
Ken‐ichi Takayama · 2019 · Biomolecules
Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia
Yalu Zhou, Cuijuan Han, Eric Wang, Adam H. Lorch, Valentina Serafin, Byoung-Kyu Cho, Blanca T. Gutierrez-Diaz, Julien Calvo, Celestia Fang, Alireza Khodadadi‐Jamayran et al. · 2020 · Cancer Discovery
Targeting splicing abnormalities in cancer
Anant A. Agrawal, Lihua Yu, Peter G. Smith, Silvia Buonamici · 2017 · Current Opinion in Genetics & Development
Myelofibrosis in 2019: moving beyond JAK2 inhibition
Michael Schieber, John D. Crispino, Brady Lee Stein · 2019 · Blood Cancer Journal
A novel ASXL1–OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignancies
Daichi Inoue, Takeshi Fujino, Paul J. Sheridan, Yaozhong Zhang, Reina Nagase, Sayuri Horikawa, Zaomin Li, Hirotaka Matsui, Akinori Kanai, Makoto Saika et al. · 2018 · Leukemia
Mutations in Splicing Factor Genes in Myeloid Malignancies: Significance and Impact on Clinical Features
Valeria Visconte, Megan O. Nakashima, Heesun Joyce Rogers · 2019 · Cancers
Polycomb/Trithorax Antagonism: Cellular Memory in Stem Cell Fate and Function
Marjorie Brand, Kiran Kumar Nakka, Jiayu Zhu, Francis Jeffrey Dilworth · 2019 · Cell stem cell
The mesenchymal niche in MDS
Eline Pronk, Marc H.G.P. Raaijmakers · 2019 · Blood
Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia
Stefanos A. Bamopoulos, Aarif M.N. Batcha, Vindi Jurinović, Maja Rothenberg‐Thurley, Hanna Janke, Bianka Ksienzyk, Julia Philippou‐Massier, Alexander Graf, Stefan Krebs, Helmut Blum et al. · 2020 · Leukemia
Deep structural insights into RNA ‐binding disordered protein regions
András Zeke, Éva Schád, Tamás Horváth, Rawan Abukhairan, Beáta Szabó, Ágnes Tantos · 2022 · Wiley Interdisciplinary Reviews - RNA
Splicing alterations in healthy aging and disease
Brittany Lynn Angarola, Olga Anczuków · 2021 · Wiley Interdisciplinary Reviews - RNA
Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene U2af1
Dennis Liang Fei, Tao Zhen, Benjamin Heath Durham, John R. Ferrarone, Tuo Zhang, Lisa J Garrett, Akihide Yoshimi, Omar Ibrahim Abdel-Wahab, Robert K. Bradley, Paul Liu et al. · 2018 · Proceedings of the National Academy of Sciences
Immune Mechanisms in Myelodysplastic Syndrome
Andreas Birkedal Glenthøj, Andreas Due Ørskov, Jakob Hansen, Sine Reker Hadrup, Casey Lee O'Connell, Kirsten Grønbæk · 2016 · International Journal of Molecular Sciences
Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis
Zioni, N., Bercovich, A. Akhiad, Chapal-Ilani, N., Bacharach, Tal, Rappoport, N., Solomon, A., Avraham, R., Kopitman, E., Porat, Z., Sacma, M. et al. · 2023 · Nature Communications
EZH2 in Myeloid Malignancies
Jenny Rinke, Andrew Chase, Nicholas C.P. Cross, Andreas Hochhaus, Thomas Ernst · 2020 · Cells
Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures
Jermaine L. Jenkins, Clara L. Kielkopf · 2017 · Trends in Genetics
Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer
Shigeki Nanjo, Wei Wu, Niki Karachaliou, Collin Michael Blakely, Junji Suzuki, Yu‐Ting Chou, Siraj Mahamed Ali, Daniel Lucas Kerr, Victor R. Olivas, Jonathan Shue et al. · 2022 · Journal of Clinical Investigation
The Multiple Facets of PRC2 Alterations in Cancers
Michel Adam Wassef, Raphaël Margueron · 2016 · Journal of Molecular Biology
Polycomb complexes in normal and malignant hematopoiesis
Valerio Di Carlo, Ivano Mocavini, Luciano Di Croce · 2018 · The Journal of Cell Biology
Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring SF3B1 or U2AF1 Mutations
Abigael Cheruiyot, Shan Li, Sridhar Nonavinkere Srivatsan, Tanzir Ahmed, Yuhao Chen, Delphine Sangotokun Lemacon, Ying Li, Zheng Yang, Brian A. Wadugu, Wayne A. Warner et al. · 2021 · Cancer Research
Epigenetic mechanisms of cell adhesion-mediated drug resistance in multiple myeloma
Yusuke Furukawa, Jiro Kikuchi · 2016 · International Journal of Hematology
RNA-binding proteins in hematopoiesis and hematological malignancy
Daniel James Hodson, Michael Screen, Martin Turner · 2019 · Blood
The Molecular Genetics of Myeloproliferative Neoplasms
Anna E. Marneth, Ann Mullally · 2019 · Cold Spring Harbor Perspectives in Medicine
Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms
Justin Taylor, Xiaoli Mi, Khrystyna North, Moritz Binder, Alexander V. Penson, Terra L. Lasho, Katherine L. B. Knorr, Michael Haddadin, Bo Liu, Joseph Pangallo et al. · 2020 · Blood
Chromatin-Based Classification of Genetically Heterogeneous AMLs into Two Distinct Subtypes with Diverse Stemness Phenotypes
Guoqiang Yi, Albertus T.J. Wierenga, Francesca Petraglia, Pankaj Narang, Eva M. Janssen‐Megens, Amit Mandoli, Angelika Merkel, Kim Berentsen, Bowon Kim, Filomena Matarese et al. · 2019 · Cell Reports
Dissecting the Contributions of Cooperating Gene Mutations to Cancer Phenotypes and Drug Responses with Patient-Derived iPSCs
Chan-Jung Chang, Andriana G. Kotini, Malgorzata Olszewska, Maria Georgomanoli, Julie Teruya‐Feldstein, Henrik Sperber, Roberto Sánchez, Robert J. DeVita, Timothy J. Martins, Omar Ibrahim Abdel-Wahab et al. · 2018 · Stem Cell Reports
Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells
Khrystyna North, Salima Benbarche, Bo Liu, Joseph Pangallo, Sisi Chen, Maximilian F. Stahl, Jan Philipp Bewersdorf, Robert F. Stanley, Caroline Erickson, Hana Cho et al. · 2022 · Nature Biotechnology
Nuclear PTEN safeguards pre-mRNA splicing to link Golgi apparatus for its tumor suppressive role
Shao-Ming Shen, Yan Ji, Cheng Zhang, Shuang-Shu Dong, Shuo Yang, Zhong Xiong, Meng-Kai Ge, Yun Yu, Xia Li, Meng Guo et al. · 2018 · Nature Communications
Complex landscape of alternative splicing in myeloid neoplasms
Courtney E. Hershberger, Devlin C. Moyer, Vera Ademà, Cassandra M Kerr, Wencke Walter, Stephan Hütter, Manja Meggendorfer, Constance Regina Baer, Wolfgang Kern, Niroshan Nadarajah et al. · 2020 · Leukemia
Epigenetics in myelodysplastic syndromes
Michael Heuser, Haiyang Yun, Felicitas R. Thol · 2017 · Seminars in Cancer Biology
Srsf2 P95H initiates myeloid bias and myelodysplastic/myeloproliferative syndrome from hemopoietic stem cells
Monique F. M. A. Smeets, Shuh Ying Tan, Jane Jialu Xu, Govardhan Anande, Ashwin Unnikrishnan, Alistair M. Chalk, Scott Taylor, John E. Pimanda, Meaghan Wall, Louise E. Purton et al. · 2018 · Blood
Integrative RNA-omics Discovers GNAS Alternative Splicing as a Phenotypic Driver of Splicing Factor–Mutant Neoplasms
Emily C. Wheeler, Shailee Vora, Daniel Mayer, Andriana G. Kotini, Malgorzata Olszewska, Samuel S. Park, Ernesto Guccione, Julie Teruya‐Feldstein, Lewis R. Silverman, Roger K. Sunahara et al. · 2021 · Cancer Discovery
MYC regulates a pan-cancer network of co-expressed oncogenic splicing factors
Laura M. Urbanski, Mattia Brugiolo, SungHee Park, Brittany Lynn Angarola, Nathan K. Leclair, Marina Yurieva, Phil Palmer, Sangram Keshari Sahu, Olga Anczuków · 2022 · Cell Reports
Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML
Joshua R. Bennett, Chiharu Ishikawa, Puneet Agarwal, Jennifer Yeung, Avery M. Sampson, Emma E. Uible, Eric J. Vick, Lyndsey C. Bolanos, Kathleen M. Hueneman, Mark Wunderlich et al. · 2023 · Blood
Structural modeling of protein–RNA complexes using crosslinking of segmentally isotope-labeled RNA and MS/MS
Georg Dorn, Alexander Leitner, Julien Boudet, Sébastien Campagne, Christine von Schroetter, Ahmed Moursy, Ruedi H. Aebersold, Frédéric H.‐T. Allain · 2017 · Nature Methods
Molecular basis of differential 3′ splice site sensitivity to anti-tumor drugs targeting U2 snRNP
Luisa Vigevani, André Gohr, Thomas R. Webb, Manuel Irimia, Juan Valcárcel · 2017 · Nature Communications
Polycomb repressive complexes in hematological malignancies
Iwama, Atsushi · 2017 · Blood
Splicing Factor Mutations in Cancer
Rafael L. Bejar · 2016 · Advances in experimental medicine and biology
ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin
Iris Tanaka, Alina Chakraborty, Olivier Saulnier, Clara Benoit‐Pilven, Sophie Vacher, Dalila Labiod, Eric W.‐F. Lam, Ivan Bièche, Olivier Delattre, Frédéric Pouzoulet et al. · 2019 · Nucleic Acids Research
Heterogeneity in myeloproliferative neoplasms: Causes and consequences
Jennifer O’Sullivan, Adam J. Mead · 2018 · Advances in Biological Regulation
Noncanonical functions of the serine‐arginine‐rich splicing factor (SR) family of proteins in development and disease
Rebecca E. Wagner, Michaela Frye · 2021 · BioEssays
Myeloproliferative neoplasms: from origins to outcomes
Jyoti Nangalia, Anthony Richard Green · 2017 · Hematology
Targeting the spliceosome machinery: A new therapeutic axis in cancer?
Béatrice Eymin · 2020 · Biochemical Pharmacology
Bone marrow inflammation in haematological malignancies
de Jong, Madelon M. E., Chen, Lanpeng, Raaijmakers, Marc H. G. P., Cupedo, Tom · 2024 · Nature reviews. Immunology
Clonal hematopoiesis and hematological malignancy
William G. Dunn, Matthew A. McLoughlin, George S. Vassiliou · 2024 · Journal of Clinical Investigation
MPN: The Molecular Drivers of Disease Initiation, Progression and Transformation and their Effect on Treatment
Julian Grabek, Jasmin Straube, Megan J. Bywater, Steven Lane · 2020 · Cells
Alternative Splicing: Expanding the Landscape of Cancer Biomarkers and Therapeutics
Cláudia Bessa, Paulo Matos, Peter Jordan, Vânia Gonçalves · 2020 · International Journal of Molecular Sciences
SRSF10: an atypical splicing regulator with critical roles in stress response, organ development, and viral replication
Lulzim Shkreta, Aurélie Delannoy, Anna Salvetti, Benoı̂t Chabot · 2021 · RNA
Alternative RNA splicing defects in pediatric cancers: new insights in tumorigenesis and potential therapeutic vulnerabilities
Akila S. Venkataramany, Kathleen M. Schieffer, K Lee, Catherine E. Cottrell, P.Y. Wang, Elaine R. Mardis, Timothy P. Cripe, Dawn S. Chandler · 2022 · Annals of Oncology
Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemias
Won Jun Kim, Edie I. Crosse, Emma De Neef, Iñaki Etxeberría, Erich Y. Sabio, Eric Wang, Jan Philipp Bewersdorf, Kuan‐Ting Lin, Sydney X. Lu, Andrea E. Belleville et al. · 2025 · Cell
Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy
Germana Castelli, Elvira Pelosi, Ugo Testa · 2017 · OncoTargets and Therapy
RNA Splicing Alterations Induce a Cellular Stress Response Associated with Poor Prognosis in Acute Myeloid Leukemia
Govardhan Anande, Nandan Deshpande, Sylvain Mareschal, Aarif M.N. Batcha, Henry R. Hampton, Tobias Herold, Sören Lehmann, Marc Ronald Wilkins, Jason W.H. Wong, Ashwin Unnikrishnan et al. · 2020 · Clinical Cancer Research
Loss-of-function mutations in the histone methyltransferase EZH2 promote chemotherapy resistance in AML
Julia Kempf, Sabrina Weser, Michael D. Bartoschek, Klaus Hans Metzeler, Binje Vick, Tobias Herold, Kerstin Völse, Raphael Mattes, Manuela Scholz, Lucas Esteban Wange et al. · 2021 · Scientific Reports
Epigenetics in normal and malignant hematopoiesis: An overview and update 2017
Susumu Goyama, Toshio Kitamura · 2017 · Cancer Science
Alternative splicing and cancer metastasis: prognostic and therapeutic applications
Diego M. Marzese, Ayla O. Manughian-Peter, Javier I. J. Orozco, Dave S.�B. Hoon · 2018 · Clinical & Experimental Metastasis
Steering research on mRNA splicing in cancer towards clinical translation
Olga Anczuków, Frédéric H.‐T. Allain, Brittany Lynn Angarola, Douglas L. Black, Angela Norie Brooks, Chonghui Cheng, Ana Conesa, Edie I. Crosse, Eduardo Eyras, Ernesto Guccione et al. · 2024 · Nature reviews. Cancer
Distinct splicing signatures affect converged pathways in myelodysplastic syndrome patients carrying mutations in different splicing regulators
Jinsong Qiu, Bing Zhou, Felicitas R. Thol, Yu Zhou, Liang Chen, Changwei Shao, Christopher DeBoever, Jiayi Hou, Hairi Li, Anuhar Chaturvedi et al. · 2016 · RNA
Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia
Antoine N. Saliba, August J. John, Scott H. Kaufmann · 2020 · Cancer Drug Resistance
Modeling ASXL1 mutation revealed impaired hematopoiesis caused by derepression of p16Ink4a through aberrant PRC1-mediated histone modification
Masahiro Uni, Yosuke Masamoto, Tomohiko Sato, Yasuhiko Kamikubo, Shunya Arai, Eiji Hara, Mineo Kurokawa · 2018 · Leukemia
Alternative splicing redefines landscape of commonly mutated genes in acute myeloid leukemia
Osvaldo D. Rivera, Michael J. Mallory, Mathieu Quesnel-Vallières, Rakesh Chatrikhi, D. Schultz, Martin P Carroll, Yoseph Barash, Sara R. Cherry, Kristen W. Lynch · 2021 · Proceedings of the National Academy of Sciences
Splicing dysregulation in cancer: from mechanistic understanding to a new class of therapeutic targets
Yongbo Wang, Yufang Bao, Sirui Zhang, Zefeng Wang · 2020 · Science China Life Sciences
Mutant SF3B1 promotes AKT- and NF-κB–driven mammary tumorigenesis
Bo Liu, Zhaoqi Liu, Sisi Chen, Michelle Ki, Caroline Erickson, Jorge Sergio Reis-Filho, Benjamin Heath Durham, Qing Chang, Elisa de Stanchina, Yiwei Sun et al. · 2020 · Journal of Clinical Investigation
Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing
Mario Cazzola, Luca Malcovati · 2015 · Hematology
Liver-Specific Deletion of SRSF2 Caused Acute Liver Failure and Early Death in Mice
Yuanming Cheng, Chunling Luo, Wenwu Wu, Zhiqin Xie, Xiang‐Dong Fu, Ying Feng · 2016 · Molecular and Cellular Biology
Environmental influences on RNA processing: Biochemical, molecular and genetic regulators of cellular response
Athma A. Pai, Francesca Luca · 2018 · Wiley Interdisciplinary Reviews - RNA
Delivery of CRISPR-Cas9 system for screening and editing RNA binding proteins in cancer
Jingyue Yan, Diana D. Kang, Gillian Turnbull, Yizhou Dong · 2021 · Advanced Drug Delivery Reviews
GPATCH8 modulates mutant SF3B1 mis-splicing and pathogenicity in hematologic malignancies
Salima Benbarche, Jose Mario Bello Pineda, Laura D. Baquero Galvis, Jeetayu Biswas, Bo Liu, Eric Wang, Qian Zhang, Simon J. Hogg, K. Ashley Lyttle, Ariana Dahi et al. · 2024 · Molecular Cell
Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment
Jung-Chun Lin · 2017 · International Journal of Molecular Sciences
The functional mechanisms of mutations in myelodysplastic syndrome
Yasunobu Nagata, Jaroslaw Pawel Maciejewski · 2019 · Leukemia
Somatic gene mutations expose cytoplasmic DNA to co-opt the cGAS/STING/NLRP3 axis in myelodysplastic syndromes
Amy F. McLemore, Hsin‐An Hou, Benjamin S. Meyer, Nghi B. Lam, Grace Ward, Amy L. Aldrich, Matthew A. Rodrigues, Alexis Vedder, Ling Zhang, Eric Padron et al. · 2022 · JCI Insight
ASCancer Atlas: a comprehensive knowledgebase of alternative splicing in human cancers
Song Wu, Yue Huang, Mochen Zhang, Zheng Gong, Guoliang Wang, Xinchang Zheng, Wenting Zong, Wei Zhao, Peiqi Xing, Rujiao Li et al. · 2022 · Nucleic Acids Research
NAT10 Phase Separation Regulates YTHDF1 Splicing to Promote Gastric Cancer Progression
Songyi Liu, Chunlin Lin, Xiang Lin, Penghang Lin, Ruofan He, Xiaoyu Norman Pan, Yan Lin, Jianxin Ye, Guangwei Zhu · 2024 · Cancer Research
Oxidized mitochondrial DNA released after inflammasome activation is a disease biomarker for myelodysplastic syndromes
Grace Ward, Kathy L. McGraw, Farnoosh Abbas Aghababazadeh, Benjamin S. Meyer, Amy F. McLemore, Nicole D. Vincelette, Nghi B. Lam, Amy L. Aldrich, Najla H. Al Ali, Eric Padron et al. · 2021 · Blood Advances
Single-cell architecture and functional requirement of alternative splicing during hematopoietic stem cell formation
Fang Wang, Puwen Tan, Pengcheng Zhang, Yue Ren, Jie R Zhou, Yunqiao Li, Siyuan Hou, Shuaili Li, Linlin Zhang, Yanni Ma et al. · 2022 · Science Advances
New Approaches to Myelodysplastic Syndrome Treatment
Alexandre Bazinet, Guillermo Montalban Bravo · 2022 · Current Treatment Options in Oncology
Emerging Therapeutic Opportunities Based on Current Knowledge of Uveal Melanoma Biology
Raquel Vivet-Noguer, Malcy Tarin, Sergio Roman‐Roman, Samar Alsafadi · 2019 · Cancers
Next Generation Sequencing in MPNs. Lessons from the Past and Prospects for Use as Predictors of Prognosis and Treatment Responses
Vibe Skov · 2020 · Cancers
Transcription elongation defects link oncogenic SF3B1 mutations to targetable alterations in chromatin landscape
Prajwal Chaitanya Boddu, Abhishek Kumar Gupta, Rahul Roy, Bárbara de la Peña Avalos, Anne Olazabal‐Herrero, Nils Neuenkirchen, Joshua T. Zimmer, Namrata S. Chandhok, Darren Patrick King, Yasuhito Nannya et al. · 2024 · Molecular Cell
Recent insights regarding the molecular basis of myeloproliferative neoplasms
Mi‐Ae Jang, Chul Won Choi · 2019 · The Korean Journal of Internal Medicine
RNase H1, the Gold Standard for R-Loop Detection
Susana M. Cerritelli, Kiran Sakhuja, Robert J. Crouch · 2022 · Methods in molecular biology
Nonsense-Mediated mRNA Decay as a Mediator of Tumorigenesis
Preeti Nagar, Md. Rafikul Islam, Mohammad Alinoor Rahman · 2023 · Genes
Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer
Koji Kitamura, Keisuke Nimura · 2021 · Cells
Molecular Pathways: Understanding and Targeting Mutant Spliceosomal Proteins
Akihide Yoshimi, Omar Ibrahim Abdel-Wahab · 2016 · Clinical Cancer Research
Emerging Therapies in CLL in the Era of Precision Medicine
Prajish Sundaram Iyer, Lili Wang · 2023 · Cancers
Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome
Paul Lee, Rita Yim, Yammy Yung, Hiu-Tung Chu, Pui-Kwan Yip, Harinder Gill · 2021 · International Journal of Molecular Sciences
R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription–Replication Conflicts
Zhiyan Silvia Liu, Sayantani Sinha, Maxwell Henry Bannister, Axia Song, Erica A. Arriaga-Gomez, Alexander J. McKeeken, Elizabeth A. Bonner, Benjamin K. Hanson, Martina Sarchi, Kouhei Takashima et al. · 2023 · Cancer Research
Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations
Johanna Flach, Johann-Christoph Jann, Antje Knaflic, Vladimir Riabov, Alexander Streuer, Eva Altrock, Qingyu Xu, Nanni Schmitt, Julia Obländer, Verena Nowak et al. · 2020 · Haematologica
A Broad Overview of Signaling in Ph-Negative Classic Myeloproliferative Neoplasms
Ana Guijarro-Hernández, J.L. Vizmanos · 2021 · Cancers
We skip to work: alternative splicing in normal and malignant myelopoiesis
Alex C. H. Wong, John E.J. Rasko, Justin J. -L. Wong · 2018 · Leukemia
Regulation of Pre-mRNA Splicing: Indispensable Role of Post-Translational Modifications of Splicing Factors
Miroslava Kretová, Tomas Selicky, Ingrid Čipáková, Luboš Čipák · 2023 · Life
Glycogen synthase kinase‐3 and alternative splicing
Xiaolei Liu, Peter S. Klein · 2018 · Wiley Interdisciplinary Reviews - RNA
Hallmarks of Splicing Defects in Cancer: Clinical Applications in the Era of Personalized Medicine
Mohammad Alinoor Rahman, Farhana Nasrin, Sonali Bhattacharjee, Saikat Nandi · 2020 · Cancers